RLYB (STOCKS)
Rallybio Corporation Common Stock
$16.960000
+0.370000 (+2.23%)
Prev close: $16.590000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Stephen Uden
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $93.90M
- Employees
- 20
- P/E (TTM)
- 2.12
- P/B (TTM)
- 0.93
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-1.46 | $-1.22 | -0.2442 | -20.09% |
|
Dec 2025 (Q4)
|
$-1.03 | $-1.20 | +0.1668 | +13.94% |
|
Sep 2025 (Q3)
|
$-1.12 | $-1.75 | +0.6289 | +35.96% |
|
Jun 2025 (Q2)
|
$-1.76 | $-2.00 | +0.2392 | +11.96% |
Financial Statements
| Revenues | $646.00K |
| Benefits Costs and Expenses | -$45.36M |
| Costs And Expenses | -$45.36M |
| Nonoperating Income/Loss | $74.60M |
| Operating Expenses | $28.37M |
| Depreciation and Amortization | $43.00K |
| Research and Development | $11.43M |
| Other Operating Expenses | $16.93M |
| Operating Income/Loss | -$27.72M |
| Income/Loss Before Equity Method Investments | $46.88M |
| Income/Loss From Continuing Operations After Tax | $44.68M |
| Income/Loss From Continuing Operations Before Tax | $46.00M |
| Income/Loss From Equity Method Investments | $0.00 |
| Income Tax Expense/Benefit | $1.32M |
| Net Income/Loss | $45.55M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $45.55M |
| Net Income/Loss Available To Common Stockholders, Basic | $45.55M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $5.05 |
| Diluted Earnings Per Share | $4.91 |
| Basic Average Shares | 11,489,353 |
| Diluted Average Shares | 17,281,973 |
| Assets | $98.06M |
| Current Assets | $97.25M |
| Cash | $92.80M |
| Other Current Assets | $4.45M |
| Noncurrent Assets | $810.00K |
| Fixed Assets | $0.00 |
| Liabilities | $3.57M |
| Current Liabilities | $3.57M |
| Accounts Payable | $833.00K |
| Other Current Liabilities | $2.73M |
| Noncurrent Liabilities | $0.00 |
| Equity | $94.50M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $94.50M |
| Liabilities And Equity | $98.06M |
| Net Cash Flow From Operating Activities | $26.71M |
| Net Cash Flow From Operating Activities, Continuing | $26.71M |
| Net Cash Flow From Investing Activities | $56.55M |
| Net Cash Flow From Investing Activities, Continuing | $56.55M |
| Net Cash Flow From Financing Activities | $140.00K |
| Net Cash Flow From Financing Activities, Continuing | $140.00K |
| Net Cash Flow | $83.40M |
| Net Cash Flow, Continuing | $83.40M |
| Comprehensive Income/Loss | $45.53M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $45.53M |
| Other Comprehensive Income/Loss | -$17.00K |